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In SK-N-SH human neuroblastoma cells, the muscarinic agonist carbachol l:romotes polyphosphoinositide (PPI) hydrolysis via M 3 recep- 
tors and increases cyclic AMP levels through an unidentified mechanism. Activation of PPI hydrolysis by carbachol elicits a robust translo- 
cation of CaM from membranes into cytosol which was previously shown to be mimicked by the addition of the calcium ionophore iono- 
mycin and the phorbol ester TPA 2s. The effect of agonist-stimulated second messenger production on CaM localization was determined by 
activating receptors that increase and decrease adenylyi cyclase activity on SK-N-SH cells. VIP (10/~M), prostaglandin E1 (30/~M) and 
forskolin (10/~M) all increased adenylyl cyclase activity 8- to 10-fold above the activity with 1/~M GTP. Carbachol (100 #M) did not stim- 
ulate adenylyl cyclase activity. The a2-adrenergic agonis~t UK 14,304 (0.1/~M) and the 6 and/z opio!d DPDPE (10/~M) and DAMGO (10 
/~M) inhibited forskolin-stimulated cyclic AMP formation I:oy 27-32%. CaM did not stimulate adenylyl cyclase activity. Incubation of cells 
with vasoactive intestinal polypeptide (VIP), dibutyryl cyclic Aivtt ~ and forskofin, resulted in 30% decrease in membrane CaM and an in- 
crease in cytosalic CaM of 40-50%. The CaM ttanslocafion with the combination of an agent that elevates cyclic AMP levels and a low dose 
of carbachoi was not different from that observed with either agent alone. UK 14,304, DPDPE and DAMGO potentiated carbachol-stim- 
ulated increases in cytosolie CaM. Upon the addition of carbachol, a 5-fold increase in intraceUular calcium concentration measured with 
fura-2 fluorescence was observed. VIP and UK 14,304 elevated intracellular calcium concentrations 2 to 3 fold, while forskolin (10/~M) had 
no effect. Thus, receptor-mediated cyclic AMP synthesis and Ca 2+ fluxes alter CaM localization, but ~vith a smaller magnitude than the CaM 
transiocation stimulated by PPI hydrolysis. 
INTRODUCTION 
Predominant receptor-mediated signal transduction 
pathways in neural tissues are the polyphosphoinositide 
(PPI) hydrolysis pathway and the adenylyl cyclase path- 
way. Recent studies have suggested that multiple signal 
transduction systems can be activated upon receptor ac- 
tivation by agonist 12't4'23. Felder et al. t4 showed that M1 
muscarinic receptor-stimulated PPI hydrolysis could lead 
to the gei~eration o f  cyclic AMP. In many systems, pro- 
tein kinase C activators can lead to changes in cyclic 
A M P  accumulation 21. For example, protein kinase 
C-stimulated phosphorylation of adenylyl cyclase has 
been shown to enhance adenylyl cyclase activity 35. Ad- 
ditionally, agents that elevate intracellular cyclic A M P  
levels have been stiow,, to affect PPI hydrolysis. Such 
agents, most likely acti~,ating cyclic AMP-dependent  
protein kina~e, have been demonstrated to inhibit mus- 
carinic receptor-stimulated PPI hydrolysis in NCB-20 
ceUs 29 and SK-N-SH cells 1. SK-N-SH human neuroblas- 
toma cells express predominantly M3 muscarinic recep- 
tors, which are coupled to activation of phospholipase C, 
and a small percentage of M2 muscarinic receptors which 
inhibit adenylyl cyclase activity. Interestingly, investiga- 
tors have reported that the muscarinic receptor agonist 
carbachol and the direct activator of PPI hydrolysis mai- 
totoxin stimulated an increase in intraceUular cyclic AMP 
levels 5'v's. This increase in cyclic AMP is not believed to 
occur through direct coupling of muscarinic receptors to 
stimulation of adenylyl cyclase. Studies in transfected 
cells have suggested that the generation of cytosolic Ca 2+ 
via muscarinic receptor-stimulated inositol triphosphate 
(IP3) release could activate CaM and a Ca2+/CaM-de - 
pendent adenylyl cyclase 12'14. 
The ubiquitous Ca2+-binding protein CaM mediates 
many Ca2+-dependent cellular functions through activa- 
tion of a variety of enzyme systems such as those in- 
volved in cyclic nucleotide metabolism, protein phospho- 
rylation and dephosphorylation, intracellular calcium 
homeostasis and smooth muscle contraction 3°. CaM has 
been shown to modulate neurotransmitter-stimulated 
adenylyl cyclase activity 2°'26 and polyphosphoinosifide 
formation by activation of IP3 kinase 24. Several studies 
have described neurotransmitter and hormone-elicited 
changes in the subcellular distribution of CaM, such as 
dopamine in the striatum ~7 and hippocampus 34, gonado- 
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tropin-releasing hormone (GnRH)  in the pituitary II, 
opiates in NG 108-15 cells 4, and isoproterenol in the pa- 
rotid gland 9. The changes in CaM distribution would al- 
low Ca2+/CaM to regulate these cellular processes at 
various loci. It has been postulated that neurotransmit- 
ter-induced calcium fluxes and activation of protein ki- 
nase C could alter CaM localization in cells 2,m. We have 
shown that the localization of CaM is altered upon car- 
bachol-stimulated PPI hydrolysis in SK-N-SH cells 2s. 
Carbachol mediated a, translocation of CaM from mem- 
branes increasing the cytosolic CaM 3- to 4-fold. Other  
studies have suggested that cyclic A M P  may play a role 
in the changes in CaM localization ~7'3~. The transloca- 
tion described by these investigators appears to be me- 
diated through a cyclic AMP-dependent  phosphorylation 
of membrane CaM-binding proteins, thus releasing CaM 
into the cytosol. In this study, we characterized the ef- 
fects of  second messenger production on the CaM trans- 
location. SK-N-SH cells express receptors coupled 
through Gs and G~ to the stimulation and inhibition of 
adenylyl cyclase activity, respectively. Both VIP and 
prostaglandin Et (PGEt)  receptors stimulate the forma- 
tiot~ of  cyclic AMP, and a2-adrenergic as well as ~t and 6 
opioid receptors inhibit the formation of cyclic A M P  5'36. 
We found that activation of the adenylyl cyclase as well 
as the PPI signal transduction systems can change CaM 
localization and affect the intracellular calcium concen- 
tration. In neural tissues and cells, diverse stimuli acti- 
vate signal transduction systems which must be inte- 
grated and regulated in order to produce a physiological 
effect. Our results suggest that CaM translocation in the 
SK-N-SH cell line may be coordinately regulated by di- 
verse as well as integrated cellular signals. A preliminary 
report of this work has appeared elsewhere 27. 
MATERIALS AND METHODS 
Materiols 
CaM radioimmunoassay (RIA) kits were purchased from New 
England Nuclear (Boston, MA). SK-N-SH human neuroblastoma 
cells and fura-2 (Molecular Probes, Eugene, OR) were generous 
gifts from Dr. Stephen K. Fisher, Department of Pharmacology, 
The University of Michigan. The source of SK-N-SH cells was as 
previously described by Fisher and Snider 16. Dulbecco's modified 
Eagle's medium was purchased from Whittaker M.A. ~ioproducts 
(Walkersville, MD). Tissue culture supplies were from Corning 
Glass Works (Coming, NY). Cell culture reagents, antibodies, fe- 
tal bovine serum, EGTA, bovine serum albumin, MgCl 2, carba- 
chol, CaC! a, Trizma, Lubrol-PX, leupeptin, pepstatin, PMSF, 
PGEI, VIP and dbcAMP were all purchased from Sigma Chemical 
Co. (St. Louis, MO). UK 14,304 and yohimbine were gifts from 
Dr. Richard Neubig, Department of Pharmacology, The Univer- 
sity of Michigan. DPDPE an0 DAMGO were gifts from Dr. Fedor 
Medzihradsky, Department of Biological Chemistry, The Univer- 
sity of Michigan. CaM was prepared from bovine testes by the method 
of Dedman et al.13 using phenyl-Sepharose chromatography. 
Cell culture and sample preparation 
Human neuroblastoma SK-N-SH cells were grown according to 
Fisher and Snider 16 in 75 cm a tissue culture flasks in 15 ml of 
Dulbecco's modified Eagle's medium supplemented with penicillin/ 
streptomycin and 10% fetal bovine serum in a humidified 5% CO2 
atmosphere at 37 °C. Cells were grown and harvested as previously 
described 2s. Briefly, the cells were collected by centrifugation, and 
resuspended in 30 mM NaHEPES buffer, pH 7.4, 142 mM NaCl, 
5.6 mM KC!, 2.2 mM CaCi 2, 3.6 mM NaHCO3, I mM MgCle, and 
5.6 mM D-glucose (buffer A). The indicated concentrations of drugs 
or vehicle were added to the cell suspension and incubated at 37 °C. 
The incubation was stopped by the addition of ice-cold saline fol- 
lowed by rapid centri~gation to collect the cells. The cells were 
homogenized in a buffer containing 40 mM Tris-HC! pH 8, 3 mM 
MgCl,, 0.32 M sucrose, 1/~M ieupeptin, 1/tM pepstatin and 1 mM 
PMSF using a teflon-glass homogenizer. The homogenate was cen- 
trifuged at 100,000 g for 1 h. The crude membrane pellet was 
resuspended in solubilization buffer containing 40 mM Tris-HCI pH 
8, 3 mM MgCl e and 0.5% Lubrol-PX. For the extraction of CaM, 
both the resuspended particulate fraction and the 100,000 g super- 
natant were diluted in a 0.125 M borate buffer, pH 8.4, containing 
75 mM NaCl, 0.2% BSA, 1 mM EGTA and 0.1% sodium azide and 
heated for 3 rain at 95 °C. 
CaM quantification 
The CaM content of the homogenate, membrane and cytosol 
fractions were determined using CaM radioimmunoassay (New En- 
gland Nuclear, Boston, MA). Bound and free CaM were separated 
using donkey anti-sheep IgG and polyethylene glycol immunopre- 
cipitation. Following centdfugation, the supernatant was discarded 
and the [1251]CaM in the pellets was quantified using gamma count- 
ing. Results obtair~ed for the preheated CaM standards were used 
to construct a standard curve from which values of the unknown 
samples were obtained by interpolation. The membrane-associated 
plus the cytosolic CaM levels routinely accounted for 75-85% of the 
homogenate values. 
Protein measurement 
The amount of protein was quantified according to Peterson 3s. 
Adenylyl cyclase assay 
The cells were washed, collected by centrifugation as above and 
homogenized in a buffer containing 10 mM Tris-HCL (pH 7.4), 1 
/~M leupeptin, 1 mM EDTA, 0.32 M sucrose and 3 mM MgCl2. 
Membranes were prepared by centrifugation for 20 rain, at 27,000 
g. Membranes were resuspended in sucrose-free homogenization 
buffer and recentrifuged. The final resuspension was in 50 mM 
NaHEPES (pH 7.4) and 3 mM MgCl2 buffer to a protein concen- 
tration of 5 mg/ml. Adenylyl cyclase activity was measured accord- 
ing to the procedure of Krishna et al. e2. Each assay tube contained 
50 mM NaHEPES buffer pH 7.4, 3 mM MgCI 2, 1 mM cyclic AMP, 
5 mM phosphoenolpyruvate, 0.5 mM IBMX, 0.2 mM EDTA, 66/~g 
BSA, 40 ~g pyruvate kinase, 0.5 mM [a-aaP]ATP (1 ~Ci) in a final 
assay volume of 100/d. The reaction mixture was incubated at 37 °C 
for 9 rain and stopped by heating for 1 min at 95 °C. All enzyme 
activities were adjusted for the recovery of [3H]cAIVtP, which was 
consistently between 85-95%. 
Measurement of cytoplasmic calcium concentrations 
Intracellular Ca 2+ concentrations ([Ca2+]i]) were measured using 
fura-2 and dual wavelength fluorimetry as desc~bed by Fisher et 
al? s. SK-N-SH cells were loaded with I/~M fura-21AM for 15 min 
at 37 °C. The loaded cells were diluted and washed in buffer A. The 
wash step was repeated, and the final resuspension was in buffer A 
to a protein concentration of approximately 3 mg/ml. Fluorescence 
measurements were made on I ml aliquots of the cells constantly 
stirred and maintained at 37 °12. The fluorimeter was an Aminco- 
Bowman spectrophotofluorimeter (excitation Z - 340 and 380 nm; 
emission ~. - 490 nm), interfaced to a s~rip chart recorder and a 
LED readout, from which quantitative fluorescence measurements 
were obtained. Maximal and minimal fluorescence ratios were cal- 
culated as described iS. Under these conditions, [Ca2+]i = 
TABLE I 
Adenylyl cyclase activities in SK-N-SH human neuroblastoma cells 
SK-N-SH cell membranes were prepared and assayed for stimula- 
tiotg (A) or inhibition (B) of adenylyl cyclase activity using the 
indicated receptor agonists. Basal adenylyl cyclase activity was 
4.0 4- 0.9 pmol/min/mg and with 1 /aM G'rP was 7.3 - 0.7 
pmol/min/mg. Inhibition of adenylyl cyclase activity was mea- 
sured in the presence of 10/aM forskolin. The data are the mean 
4- S.E.M. for two experiments performed in triplicate. 
Agonist Stimulation above % Inhibition 





10/aM VIP 76 - 6 
30/aM PGE~ 62 - 4 
10/~M carbachol 1.4 _ 1" 
100/aM carbachol 1 -4- 1" 
10/aM forskolin 60 __. 5 
10/aM carbachol 53 +- 7 12 
100/aM carbachol 48 4- 4** 20 
0.1/aM UK 14,304 42 --- 3** 30 
10/aM DPDPE 44 -4- 3** 27 
10/aM DAGOL 41 +- 2** "? 
* Not significantly different from 1/aM GTP. 
** Significantly different from 10/aM forskolin (P < 0.01). 
(R-Rmin/Rmax-R) B (Kd), where R, Rmi n, and Rma x are the ratios 
of the fluorescence obtained at 340 nm and 380 nm, correlated for 
autofluorescence. B is the ratio of fluorescence of Ca2+-freelCa 2+- 
saturated fluorescence signals at 380 nm. 
RESULTS 
SK-N-SH cells express receptors coupled to adenylyl cy- 
clase activities 
SK-N-SH cells express receptors coupled to stimula- 
tion and inhibition of adenylyl cyclase activity. Both VIP 
(10/~M) and PGE1 (30/~M) increased adenylyl cyclase 
activity 9- to 10-fold above the activity with 1/~M GTP 
(Table IA). Although carbachol has been shown to in- 
crease intracellular cyclic AMP levels in these cells 7, car- 
bachol did not stimulate adenylyl cyclase activity at con- 
centrations of 10/~M or 100/~M. The diterpene forskolin, 
which is thought to directly activate the catalytic activity 
of adenylyl cyclase, stimulated activity 8.5-fold above 
GTE Agonists acting through receptors that are coupled 
to inhibition of adenylyl cyclase through Gi (Table IB) 
were assayed for inhibition of forskolin-stimulated ade- 
nylyl cyclase activity. Carbachol, acting through M2 mus- 
carinic receptors, modestly inhibited forskolin-stimulated 
adenylyi cyc!ase activity by 12% (10/~M) and 20% (100 
#M). The a2-adrenergic agonist UK 14,304 (0.1/~M) and 
the opioid receptor agonists n-pen, a-pen enkephalin 
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Fig. 1. Effect of Ca .'+ and CaM on adenylyl cyclase activity in SK- 
N-SH cell membranes. SK-N-SH cell membranes were prepared 
and washed twice with a 1 mM EDTA-containing homogenization 
buffer (see Materials and Methods) to remove endogenous CaM. 
Adenylyl cyclase activity was measured in the presence of different 
CaCI a concentrations without (o) and with (O) 3/ag CaM as de- 
scribed in Materials and Methods. Basal adenylyl cyclase activity 
was 5.8 pmol/min/mg protein. The final EDTA concentration in the 
100/ai assay volume was 200/aM. The data are representative of 5 
separate experiments performed in triplicate. 
(DAMGO) (10/~M) each inhibited forskolin-stimulated 
cyclic AMP formation by 27-32%. SK-N-SH cell mem- 
branes that were depleted of endogenous CaM were as- 
sayed for the presence of CaM-stimulated adenylyl cy- 
clase activity (Fig. 1). Adenylyl cyclase activity was 
inhibited with increasing concentrations of CaCI2, from 
a basal activity of 5.8 pmol/min/mg to 3.3 pmol/min/mg 
at 200 #M CaCI2. The addition of 3 #g of CaM did not 
significantly change the activity in the presence of Ca 2+ 
alone. 
Increased cyclic A M P  levels affect CaM localization 
The ability of cyclic AMP to mediate translocation of 
CaM in SK-N-SH cells was determined. Both forskolin 
(10/~M) and the cyclic AMP analogue dibutyryl cyclic 
AMP (dbcAMP) (1 mM) elicited a translocation of CaM 
from membranes into cytosoi, with a decrease in mem- 
branes of 30% and an increase in total CaM in the cy- 
tosol of 40-50% (Fig. 2). This result is similar to that 
observed with the lower dose of 1 #M carbachol which 
is approximately the EC50 for carbachol-stimulated CaM 
translocation 28. Receptor-stimulated increases in cyclic 
AMP levels induced by VIP (10/tM) also changed the 
distribution of CaM, with a decrease in the membranes 
of 29% and an increase in the cytosol of 40%. Incuba- 
tion of cells with PGE~, however, did not affect CaM 
localization even though it stimulated adenylyl cyclase 
activity to a similar extent as VIP (data not shown). The 
effect of the combination of carbachol and ager~ts that 
elevate intracellular cyclic AMP levels on CaM u'anslo- 
cation is shown in Table II. The combinations of carba- 
chol with forskolin, dbcAMP, and VIP did not change 
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TABLE II 
Effects of combinations of agents that elevate cyclic AMP with 
carbachoi 
Cells were incubated with combinations of agents for 15 rain at 
37 °C. CaM quantitation was by RIA. The concentrations of the 
agents employed are the same as those shown in Fig. 2. The 
data represent the mean -+ S.E.M. for three experiments per- 
formed in duplicate, except for VIP, the data represent the mean 
of two experiments performed in duplicate. Control values 
(100%) were 48 +- 6 ng CAM/106 cells for the membranes and 47 
--+ 7 ng CAM/106 cells for the cytosol, carb, carbachol; Forsk, 
Forskolin. 
Agent % Control 
Membrane Cytosol 
1/~M carb 69 -+ 8 142 -+ 7 
dbcAMP • carb 66 -+ 9 148 ± 8 
VIP . . . .  75 134 
PGE1 + . 60-- 6 126-- 9 
10/~M ,~ .... 43 -+ 3 275 +- 18 
Forsk -- 10 #M carb 58 _+ 10 228 -+ 32 
the degree of translocation of CaM observed with cyclic 
AMP-elevating agents alone or carbachol alone. The 
combination of carbachol and PGE~ caused a CaM 
translocation of similar magnitude to that observed with 
1/~M carbachol alone. The combination of forskolin and 
a nearly maximal concentration of carbachol was also 
not additive, and did not differ from carbachol alone. 
Agonists that decrease intracellular cyclic AMP levels po- 
tentiate carbachol-stimulated increases in cytosolic CaM 
Carbachol did not directly stimulate adenylyl cyclase 
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Fig. 2. Increased intraceilular cyclic AMP elicits a CaM transloca- 
tion. Cells were incubated with 10 #M or 1 #M carbachol (carb), 1 
mM dibutyryl cyclic AMP (dbcAMP), 10 luM forskolin (forsk), or 
10 #M VIE CaM quantification was by RIA. The data show the 
mean _+ S.E. for three experiments performed in duplicate, except 
for VIE for which the data represent the average of tw~ experi- 
ments in duplicate. Control values (100%) were 48 _+ 6 l,g CaM/ 
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Fig. 3. Effect of agonists negatively coupled to adenylyl cyclase on 
CaM localization. Cells were incubated with 1 mM carbachol (carb), 
0.1 /~M UK 14,304 (UK), 10 #M a-pen, D-pen enkephalin 
(DPDPE) alone or in combination with 1/~M carbachol for 15 mia 
at 37 °(2. CaM quantification was by RIA. The data represent three 
determinations performed in duplice~te. Control (100%) values were 
57 +- 8 ng CAM/106 cells for the membranes and 53 -- t5 ng CaM/ 
106 cells for the cytosol. *Significantly different from 1/~M carba- 
chol P < 0.05. 
AMP levels in these cells. We investigated the effect of 
agonists that bind to receptors negatively coupled 
through Gi to adenylyl cyclase activity on the carbachol- 
stimulated CaM translocation. Activation of these recep- 
tors would directly inhibit cyclic AMP formation. Nei- 
ther the a2-adrenergic agonist UK 14,304 (0.1 I,M) nor 
the opioid receptor agonists DPDPE (10 uM) and 
D A M G O  (10 #M) affected the cellular distribution of 
CaM (Fig. 3). However,  both UK 14,304 and DPDPE 
significantly potentiated the carbachol-stimu~lated in- 
crease in cytosolic CaM by 36%. The a2-adrenergic re- 
ceptor antagonist yohimbine (10 #M) blocked the UK 
14,304-mediated potentiation of carbachol-:;timulated 
translocation of CaM (data not shown). 
Measurement of  cytoplasmic Ca 2+ concentrations in agon- 
ist-stimulated SK-N-SH cells 
Intracellular calcium [Ca2+]i is elevated by many hor- 
mones and neurotransmitters and is required for CaM 
activation. Slate changes in [Ca2+]i may be an important 
stimulus for CaM translocation, basal and agonist-stim- 
ulated [Ca2+]i values in SK-N-SH were monitored using 
fura-2 and dual wavelength measurements. The basal 
[Ca2+]i of quiescent SK-N-SH cells was 40 _+ 11 nM 
(n = 10) which corresponds to values previously re- 
ported ~5. Carbachol stimulated a rapid increase in [Ca2+]i 
to a peak of 282 -+ 10 nM, followed by a gradual de- 
cline to a plateau level of 104 +- 7 nM (Fig. 4A). VIP, 
which stimulated adenylyl cyclase activity (Table IA),  
also increased [Ca2÷]i, however, to a mu.ch smaller ex- 
tent with a peak rise of 186 +_ 44 nM (n = 4) (Fig. 4]]). 
VIP-stimulated Ca 2+ fluxes were not observed if the cells 
were pre-stimulated with carbachol. Forskolin did not 
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Fig. 4. A-C: effect of agonist stimulation on [Ca2+]i monitored by 
fura-2 fluorescence. Cells were loaded with 1/~M fura-2/AM for 15 
min at 37 °C. At the times indicated, the agonists were added. A: 
100/~M carbachol (carb). B: 10/~M VIE C: 50 nM UK 14,304 
(UK). 
The a2 agonist UK 14,304 elicited a rise in [Ca2+]i to a 
peak of 130 -- 10 nM (n = 4) (Fig. 4C). Like VIP, UK 
14,304 did not affect [CaZ+]i when carbachol was added 
to the cells first. The ability of VIP or UK 14,304 to po- 
tentiate muscarinic receptor-stimulated Ca 2+ responses 
was assessed using 1 #M carbachol, and little or no po- 
tentiation was observed (data not shown). 
DISCUSSION 
We have used the SK-N-SH human neuroblastoma 
cell line to investigate the effect of second messenger 
production on the distribution of CaM. In these cells, 
the muscarinic agonist carbachoJ promotes PPI turnover 
via M 3 receptors s6, modestly inhibits adenylyl cyclase ac- 
tivity via M2 receptors (see Results), and increases in- 
tracellular cyclic AMP levels s'7. The mechanism for the 
increased cyclic AMP levels does not appear to be 
through CaM stimulation of adenylyl cycla.~e, since we 
were unable to detect a stimulatory effect of added 
CaM, and actually observed a slight inhibition of activ- 
ity. Carbachol can also stimulate a robust translocation 
of CaM from membranes into the cytosol 2s, thus increas- 
ing the availability of 'free' CaM to regulate various 
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Ca2+/CaM-dependent enzyme systems such as CaM-de- 
pendent protein kinases, calcineurin, phosphodiesterase 
or Ca 2+ transport systems. The mechanism of the release 
involves both intracellular Ca 2+ and protein kinase C 
activity. Previous work has suggested a role fm cyclic 
AMP-dependent phosphorylation in neurotransmitter- 
induced changes in CaM localization 17'31. Many CaM- 
dependent enzymes and -binding proteins are substrates 
for cyclic AMP-dependent protein kinase. The current 
study demonstrates that agents elevating iutracellular cy- 
clic AMP levels such as forskolin, dbcAMP and VIP can 
decrease CaM content in membranes and increase CaM 
levels in the cytosol of SK-N-SH cells. The CaM trans- 
location mediated by cyclic AMP, however, is signifi- 
cantly lower than that elicited by PPI hydrolysis, which 
would give the greatest response physiologically. 
Since stimulation of both the adenylyl cyclase and 
PPI ~ systems can affect CaM localization, then the ac- 
tivation of protein kinase C or cyclic AMP-dependent 
protein kinase may be mechanistically important in trans- 
location. The phosphorylation of a membrane of cyto- 
solic CaM-binding protein which is a substrate for both 
protein kinase C and cyclic AMP-dependent protein ~ 
nase could release CaM. Recent studies have demon- 
strated that some CaM-binding proteins such as neuro- 
modulin 3, MARCKS protein la, and neurogranin 6 are 
substrates for protein kinases, and the phosphorylated 
forms of the CaM-binding proteins have a lower affinity 
for CaM. If phoshorylation of a membrane-bound CaM- 
binding protein were the mechanism of the transloca- 
tion, the~ the decrease of CaM in the membrane should 
approximate the increase in CaM in the cytosol. The 
PKC-activating phorbol ester TPA decreased membrane 
CaM and increased cytosolic CaM to the same extent 2s. 
In this study V!P stimulated a 30% decrease in mem- 
brane CaM (15 ng) and 40% increase in cytosolic (20 ng) 
CaM. Therefore, phosphorylation of CaM-binding pro- 
teins by cyclic AMP-dependent protein kinase may ini- 
tiate these changes in CaM localization. We are currently 
investigating CaM-binding proteins phosphorylated in 
reei~onse to carbachol and agents that increase cyclic 
AMP levels. 
Elevations in [Ca2+Ii contribute to the mechanism of 
the translocation of CaM as shown in previous studies 
using the ionophore ionomycin 2s. Our work and others 32 
demonstrate that VIP can elicit a Ca e+ signal in these 
cells. It appears that the mechanism of the VIP-stimu- 
lated Ca e+ flux is distinct from stimulation of adenylate 
cyclase activity, however, since forskolin did not change 
[cae+]i . Thus, VIP, forskolin and dbcAMP increased cy- 
clic AMP levels and elicited a CaM translocation prob- 
ably not via changes in [Ca2+]i, but instead through cy- 
clic AMP-dependent protein kinase activation. 
The cych~, AMP and carbachol-stimulated transloca- 
tions were not additive and there could be several ex- 
planations for this finding. Cyclic AMP and PPI hydrol- 
ysis may be acting through a common pathway to elicit 
a CaM translocation, for example, phosphorylation of 
the same target protein. Alternatively, the cyclic AMP- 
sensitive pool of CaM could be contained within the 
larger PPI-sensitive pool; thus the response observed 
with a combination of agents would not be greater than 
the larger of the two pools. The data do not indicate if 
the carbachol or the cyclic AMP response predominates. 
Interactions between these two signal transduction sys- 
tems have been described, but appear to differ depend- 
ing on the tissue or cell type employed in the study. Ac- 
tivation of specific protein kinase C isozymes in PC12 
and transfected NIH 3T3 cells induced changes, both fa- 
cilitatory and inhibitory, in cyclic AMP accumulation t9. 
In another study, increased intracellular cyclic AMP lev- 
els in SK-N-SH cells inhibited PPI turnover at a site di- 
stal to the G protein coupled to phopholipase C ~. Incu- 
bation of the cells with cyclic AMP analogues or forskolin 
as well as guanine nucleotides in permeabilized cells in- 
hibited PPI hydrolysis by 20-70%. In this same study, 
PGE~ did not affect PPI turnover, and interestingly, we 
describe that it does not affect CaM localization. The 
non-additivity observed with regard to  the cyclic AMP 
and PPI effects on CaM, however, is not likely to result 
from cyclic AMP-mediated inhibition of the carbachoi 
response since forskolin did not significantly inhibit CaM 
translocation elicited by 10 #M carbachol. In addition, 
carbachol activation of the M3 muscarinic receptors 
present on these cells was still able to stimulate a robast 
PPI response 16 and a rise in cyclic AMP levels 7. Baron 
and Siegel 5 have shown that stimulation of muscarinic 
receptors by carbachol actually augments the forskolin 
and VIP-stimulated cyclic AMP accumulation in SK- 
N-SH cells. Our data show that VIP and forskolin have 
effects when added alone and do not require PPI turn- 
over to elicit changes in CaM localization. It has been 
postulated that the carbachol-induced elevation in cyclic 
AMP secondary to PPI turnover occurs through a CaM- 
stimulation of adenylyl cyclase. We found no evidence 
to support this in SK-N-SH cells, however. 
Agonists which inhibit adenylyl cyclase potentiated 
the carbachol-stimulated CaM translocation, resulting in 
greater levels of cytosolic CaM. Alpha2-adrenergic re- 
ceptor activation has been reported to stimulate a vari- 
ety of second messenger systems in addition to inhibi- 
tion of adenylyl cyclase activity, such as Na+/H + antiport 
and phospholipase A2 activity 25. In addition, UK 14,304 
has been reported to have a modest ability to stimulate 
PPI metabolism and increase intracellular Ca 2+ via a cy- 
clic AMP-independent mechatfism as well as inhibiting 
adenylyl cyclase activity in transfected cells ~2. We and 
others 5 show that UK 14,304 inhibits forskolin-stimu- 
lated adenylyl cyclase activity in SK-N-SH cells. UK 14, 
304 also generated a Ca 2+ signal in SK-N-SH cells, but 
did not appear to potentiate the carbachol-stimulated 
Ca 2+ flux, although variable results were obtained. The 
potentiative effects of UK 14,304 on CaM content may 
be mediated through multiple interacting signaling sys- 
tems since UK 14,304 had an effect on CaM only in the 
presence of added carbachol. Indeed, UK 14,304 was 
shown to be significantly less effective in inhibiting for- 
skolin-stimulated adenylyl cydase activity in the pres- 
ence of carbachol 5. The mechanism of the opiate recep- 
tor-mediated potentiation of carbachol-stimulated CaM 
translocation is not dear, although DPDPE and 
DAMGO inhibited adenylyl cyclase activity in these 
cells. Enkephalins have been reported to stimulate the 
redistribution of CaM in NG 108-15 cells 4, however, our 
data show that DPDPE and DAMGO have effects only 
in the presence of carbachol. Activation of other second 
messenger pathways has not been linked to these recep- 
tors, but it is possible that as yet unidentified interactions 
between opiate and carbachol-stimulated processes can 
occur. 
The outcome of receptor-G-protein-effector interac- 
tions in whole cells is influenced by biochemical events 
other than those which occur in isolated membranes in 
response to singular stimuli. In neural tissues and cells, 
signal transduction systems are activated by diverse stim- 
uli, and these signals are integrated and regulated in or- 
der to produce the physiological response. CaM has 
been described as a 'multifunctional regulator '1° because 
of its pivotal ability to regulate activities important in 
both Ca 2+ and cyclic AMP signal cascades. We demon- 
strate that activation of either PPI hydrolysis or adeny- 
lyl cyclase activity results in a translocation of CaM. In 
addition, the two pathways can interact to effect an even 
greater increase in CaM in the cytosol. These changes in 
CaM localization could allow altered regulation of CaM- 
dependent enzyme systems at specified cellular locations. 
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